Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy According to Treatment Timing in Immunocompromised Patients Treated With Itraconazole Injection as an Empiric Antifungal Therapy

NCT01060462 is registered in ClinicalTrials.gov with Janssen Korea, Ltd., Korea as lead sponsor.

NCT NCT01060462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01060462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy According to Treatment Timing in Immunocompromised Patients Treated With Itraconazole Injection as an Empiric Antifungal Therapy
Lead sponsor
Janssen Korea, Ltd., Korea
Phase
Observational
Overall status
Completed
Start date
August 31, 2008
Completion date
February 28, 2009
Enrollment
438 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

fever, hematological malignancies, neutropenia